Q
Qun-fang Lin
Researcher at Hunan University
Publications - 4
Citations - 14
Qun-fang Lin is an academic researcher from Hunan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 1 publications receiving 1 citations.
Papers
More filters
Journal ArticleDOI
Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer via Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
Yongrong Wu,Xujun You,Qun-fang Lin,Weiwei Xiong,Yinmei Guo,Zhen Huang,Xinjun Dai,Zhengjia Nelson Chen,Si Mei,Yan Long,Xuefei Tian,Qing Zhou +11 more
TL;DR: PI3K/Akt/mTOR pathway-related pathway proteins were confirmed as the potential XHP-associated targets for PCa and can suppress the proliferation of prostate cancer via inhibitions of the PI3K/, Akt, and mTOR pathway.
Journal ArticleDOI
Chlorogenic Acid Prevents Microglia-Induced Neuronal Apoptosis and Oxidative Stress under Hypoxia-Ischemia Environment by Regulating the MIR497HG/miR-29b-3p/SIRT1 Axis
Yong Fan,Yongkun Li,Yongkai Yang,Ku-Hung Lin,Qing Qiang Lin,Sheng-Ching Luo,Xiaohui Zhou,Qun-fang Lin,Fan Zhang +8 more
TL;DR: CGA upregulates MIR497HG to curb miR-29b-3p expression, hence initiating the SIRT1/NF-κB signaling pathway and repressing OGD-elicited inflammation, oxidative stress, and neuron apoptosis.
Journal ArticleDOI
Chlorogenic acid promotes angiogenesis and attenuates apoptosis following cerebral ischaemia-reperfusion injury by regulating the PI3K-Akt signalling
Yong Fan,Yongkun Li,Yongkai Yang,Ku-Hung Lin,Qing Qiang Lin,Shenghui Luo,Xiaohui Zhou,Qun-fang Lin,Fan Zhang +8 more
TL;DR: This research provides a theoretical basis for the use of CGA in the treatment of ischaemic stroke by effectively repressed apoptosis and promoted angiogenesis in OGD/R-treated HBMECs and MCAO-treated mice by modulating PI3K-Akt signalling.
Patent
Traditional Chinese medicine combination for treating chronic prostatitis and preparation method thereof
TL;DR: In this article, a traditional Chinese medicine combination for treating chronic prostatitis and a preparation method thereof are described. But the preparation method is not suitable for the treatment of chronic prostate cancer, as it requires a large amount of raw materials, such as yam rhizome, grassleaf sweetflag rhizomes, lycopus herb, barbed skullcap herb, spreading hedyotis herb and cowherb seed.